Ascendis Pharma AS
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops TransCon toll like receptors 7/8 agonist for intratumoral delivery; and TransCon IL-2 ß/g for systemic delivery. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark. Show More...
-
Website https://ascendispharma.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 162.84 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share EUR 0.12 0.38 -0.57 -1.39 -2.58 -3.68 -3.17 -4.69 -4.77 Dividends EUR Payout Ratio % * Shares Mil 11.0 11.0 17.0 24.0 27.0 34.0 41.0 47.0 48.0 Book Value Per Share * USD 5.73 2.43 6.53 8.26 15.43 12.7 Free Cash Flow Per Share * USD -1.82 -2.29 -3.29 -3.71 -4.16 Return on Assets % 5.18 15.66 -22.63 -34.57 -42.57 -61.79 -49.1 -43.79 -32.92 Financial Leverage (Average) 16.33 4.24 1.28 1.1 1.08 1.13 1.14 1.13 1.13 Return on Equity % 139.74 103.83 -37.07 -39.63 -46.14 -68.11 -55.68 -49.71 -35.99 Return on Invested Capital % 116.04 104.01 -37.01 -39.64 -46.22 -68.56 -57.35 -47.74 -36.88 Interest Coverage 65.25 589.13 -645.25 -177.75 -153.64 Current Ratio 0.87 1.04 4.13 10.98 13.67 8.61 7.53 12.74 13.19 Quick Ratio 0.86 1.04 4.09 10.65 13.52 8.32 7.21 12.58 12.95 Debt/Equity 0.05 0.06